Search Within

Martin Stuart Tallman

  1. "Pediatrics, Department of"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (8)
Groups
  1. Adult Leukemia (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Hematologic Malignancies, Division of (18)
  5. Pediatrics, Department of (18)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (15)

More Groups

People
  1. Ross Levine (13)
  2. Barbara Spitzer (8)
  3. Eytan Stein (5)
  4. Minal Patel (5)
  5. Sean Devlin (5)
  6. Ahmet Zehir (4)

More People

Years
  1. 2022 (2)
  2. 2020 (3)
  3. 2019 (2)
  4. 2018 (3)
  5. 2017 (2)
  6. 2016 (3)

More Years

Publications
  1. Blood (6)
  2. Biology of Blood and Marrow Transplantation (2)
  3. Cancer Discovery (2)
  4. Cancer Research (2)
  5. Haematologica (1)
  6. Leukemia (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (3)
  4. Elsevier Inc. (2)
  5. Elsevier Ltd (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (18)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features
    Journal Article

    Epstein-Peterson, Z. D.; Spitzer, B.; Derkach, A.; Arango, J. E.; McCarter, J. G. W.; Medina-Martínez, J. S.; McGovern, E.; Farnoud, N. R.; Levine, R. L.; Tallman, M. S.
    Leukemia Research (2022)

    Fulltext@MSK | Save
  • Intracellular cholesterol pools regulate oncogenic signaling and epigenetic circuitries in early T-cell precursor acute lymphoblastic leukemia
    Journal Article

    Rashkovan, M.; Albero, R.; Gianni, F.; Perez-Duran, P.; Miller, H. I.; Mackey, A. L.; Paietta, E. M.; Tallman, M. S.; Rowe, J. M.; Litzow, M. R.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia
    Journal Article

    Oshima, K.; Zhao, J.; Pérez-Durán, P.; Brown, J. A.; Patiño-Galindo, J. A.; Chu, T.; Quinn, A.; Gunning, T.; Belver, L.; Ambesi-Impiombato, A.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes
    Meeting Abstract

    Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • AML with mutations in IDH1 and DNMT3A exhibits a distinct epigenetic signature with poorer overall survival
    Meeting Abstract

    Ahr, K.; Famulare, C.; Koche, R.; Spitzer, B.; Levine, R. L.; Tallman, M. S.; Goldberg, A. D.; Stein, E. M.; Glass, J. L.
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
    Journal Article

    Brown, F. C.; Still, E.; Koche, R. P.; Yim, C. Y.; Takao, S.; Cifani, P.; Reed, C.; Gunasekera, S.; Ficarro, S. B.; Romanienko, P.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save